World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
84
Citations
24716
World Ranking
931
National Ranking
58

Medicine

D-Index
90
Citations
29601
World Ranking
12210
National Ranking
662

Overview

Roland Buhl is affiliated with Johannes Gutenberg University of Mainz in Germany. Their research is primarily concentrated in the field of medicine, with a strong focus on pulmonary and respiratory medicine. Other subfields include physiology, immunology and allergy, emergency medical services, and surgery.

The main topics covered in Roland Buhl's work include:

  • Asthma and respiratory diseases
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Respiratory and Cough-Related Research
  • Inhalation and Respiratory Drug Delivery
  • Allergic Rhinitis and Sensitization
  • Respiratory Support and Mechanisms
  • Pediatric health and respiratory diseases

Among the recent publications associated with Roland Buhl are:

  • Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes, 2021, European Respiratory Journal
  • Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update, 2023, npj Primary Care Respiratory Medicine
  • European Respiratory Society guidelines for the diagnosis of asthma in adults, 2022, European Respiratory Journal
  • Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study, 2023, The Lancet Respiratory Medicine
  • Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes, 2021, The Journal of Allergy and Clinical Immunology In Practice

Frequent coauthors in Roland Buhl's research collaborations include:

  • Christian Taube
  • Stephanie Korn
  • Eckard Hamelmann
  • Katrin Milger
  • Claus Vogelmeier

Roland Buhl's publications have appeared notably in the following venues:

  • Pneumologie
  • The Journal of Allergy and Clinical Immunology In Practice
  • European Respiratory Journal
  • Allergy
  • Respiratory Medicine

Best Publications

  • Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.

    Ian D Pavord;Stephanie Korn;Peter Howarth;Eugene R Bleecker

  • High-Dose Acetylcysteine in Idiopathic Pulmonary Fibrosis

    Maurits Demedts;Juergen Behr;Roland Buhl;Ulrich Costabel

  • The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics.

    Unknown

  • Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer—what limits limited disease?

    Patrick Micke;Andreas Faldum;Tsegay Metz;Kai-Michael Beeh

  • Systemic deficiency of glutathione in cystic fibrosis.

    J. H. Roum;R. Buhl;N. G. McElvaney;Z. Borok

  • The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma

    J. Bousquet;P. Cabrera;N. Berkman;R. Buhl

  • Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases

    Oliver Pfaar;Claus Bachert;Albrecht Bufe;Roland Buhl

  • Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4)

    Roland Buhl;François Maltais;Roger Abrahams;Leif Bjermer

  • Revisiting Type 2‐high and Type 2‐low airway inflammation in asthma: current knowledge and therapeutic implications

    D. Robinson;M. Humbert;R. Buhl;A. A. Cruz

  • GINA 2019: a fundamental change in asthma management: Treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and adolescents

    Helen K Reddel;J Mark FitzGerald;Eric D Bateman;Leonard B Bacharier

  • Overall asthma control: The relationship between current control and future risk

    Eric D. Bateman;Helen K. Reddel;Göran Eriksson;Göran Eriksson;Stefan Peterson

  • Efficacy of a new once-daily long-acting inhaled beta2-agonist indacaterol versus twice-daily formoterol in COPD.

    Ronald Dahl;Kian Fan Chung;Roland Buhl;Helgo Magnussen

  • Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations

    P. Kuna;M. J. Peters;A. I. Manjra;C. Jorup

  • Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update

    Unknown

  • Neutrophil Chemotactic Activity of Sputum From Patients With COPD: Role of Interleukin 8 and Leukotriene B4

    Kai M. Beeh;Oliver Kornmann;Roland Buhl;Sarah V. Culpitt

  • Allergen-induced asthmatic responses modified by a GATA3-specific DNAzyme.

    Norbert Krug;Jens M Hohlfeld;Anne-Marie Kirsten;Oliver Kornmann

  • Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature.

    Timm Volmer;Timo Effenberger;Christoph Trautner;Roland Buhl

  • Safety and tolerability of omalizumab

    J. Corren;T. B. Casale;B. Lanier;R. Buhl

  • Adenovirus-Mediated Wild-Type p53 Gene Transfer in Patients Receiving Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Results of a Multicenter Phase II Study

    M. Schuler;R. Herrmann;J. L.P. De Greve;A. K. Stewart

  • Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma.

    Sumita Khatri;Wendy Moore;Peter G. Gibson;Richard Leigh

  • MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

    J. Bousquet;H. J. Schunemann;J. Fonseca;B. Samolinski

  • Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone.

    Olle Zetterström;R Buhl;H Mellem;M Perpina

Frequent Co-Authors

Claus Vogelmeier
Claus Vogelmeier Philipp University of Marburg
Christian Taube
Christian Taube Johannes Gutenberg University of Mainz
Jean Bousquet
Jean Bousquet University of Montpellier
Ludger Klimek
Ludger Klimek Ghent University
Claus Bachert
Claus Bachert Karolinska Institute
Marc Humbert
Marc Humbert University of Paris-Saclay
Eric D. Bateman
Eric D. Bateman University of Cape Town
Thomas Keil
Thomas Keil University of Würzburg
Thomas B. Casale
Thomas B. Casale University of South Florida
Peter Schmid-Grendelmeier
Peter Schmid-Grendelmeier University of Zurich

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring related online degrees can open doors to diverse career opportunities in health and science fields. Many professionals enhance their qualifications through accredited online mph programs easy to get into. These public health degrees complement microbiology knowledge, broadening expertise in disease prevention and health management.

Alternative career pathways include becoming a child life specialist, a role focused on supporting children’s emotional wellbeing in medical settings. This field integrates biological sciences with psychology and social support skills, appealing to those with a microbiology background who want direct patient interaction.

For those facing unique challenges, certain degrees offer accessible options. The degrees felons can get list highlights online programs that provide second chances while building a solid career foundation, including some related to health sciences.

Moreover, pursuing advanced roles such as a functional medicine nurse practitioner can be rewarding both professionally and financially. Insights into the functional medicine nurse salary showcase how interdisciplinary medical knowledge can translate into a lucrative healthcare career.

Best Scientists Citing Roland Buhl

Trending Scientists

Recently Published Articles